10-18506518-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_201596.3(CACNB2):​c.641G>C​(p.Ser214Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00106 in 1,611,704 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S214N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00087 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 6 hom. )

Consequence

CACNB2
NM_201596.3 missense

Scores

9
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:8

Conservation

PhyloP100: 7.03

Publications

15 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • cardiogenetic disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01582411).
BP6
Variant 10-18506518-G-C is Benign according to our data. Variant chr10-18506518-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 161211.
BS2
High AC in GnomAd4 at 133 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.641G>Cp.Ser214Thr
missense
Exon 6 of 14NP_963890.2Q08289-1
CACNB2
NM_201590.3
MANE Plus Clinical
c.479G>Cp.Ser160Thr
missense
Exon 5 of 13NP_963884.2Q08289-3
CACNB2
NM_201597.3
c.641G>Cp.Ser214Thr
missense
Exon 6 of 14NP_963891.1Q08289-8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.641G>Cp.Ser214Thr
missense
Exon 6 of 14ENSP00000320025.8Q08289-1
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.479G>Cp.Ser160Thr
missense
Exon 5 of 13ENSP00000366546.4Q08289-3
CACNB2
ENST00000352115.10
TSL:1
c.641G>Cp.Ser214Thr
missense
Exon 6 of 14ENSP00000344474.6Q08289-8

Frequencies

GnomAD3 genomes
AF:
0.000874
AC:
133
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00110
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00100
AC:
251
AN:
250608
AF XY:
0.00116
show subpopulations
Gnomad AFR exome
AF:
0.000310
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000323
Gnomad NFE exome
AF:
0.00146
Gnomad OTH exome
AF:
0.000655
GnomAD4 exome
AF:
0.00108
AC:
1574
AN:
1459376
Hom.:
6
Cov.:
29
AF XY:
0.00109
AC XY:
793
AN XY:
726198
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33424
American (AMR)
AF:
0.000671
AC:
30
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39604
South Asian (SAS)
AF:
0.00114
AC:
98
AN:
86196
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53394
Middle Eastern (MID)
AF:
0.00434
AC:
25
AN:
5760
European-Non Finnish (NFE)
AF:
0.00118
AC:
1315
AN:
1109878
Other (OTH)
AF:
0.00104
AC:
63
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
66
132
197
263
329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000873
AC:
133
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.000873
AC XY:
65
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41586
American (AMR)
AF:
0.00163
AC:
25
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4828
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00110
AC:
75
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000986
Hom.:
0
Bravo
AF:
0.000756
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000988
AC:
120
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Brugada syndrome 4 (3)
-
-
3
not provided (3)
-
2
1
not specified (3)
-
-
1
Brugada syndrome (1)
-
-
1
Cardiovascular phenotype (1)
-
1
-
Early repolarization associated with ventricular fibrillation (1)
-
1
-
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.040
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
T
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
-0.16
T
MutationAssessor
Benign
0.69
N
PhyloP100
7.0
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.0
N
REVEL
Uncertain
0.36
Sift
Uncertain
0.010
D
Sift4G
Benign
0.14
T
Polyphen
0.0010
B
Vest4
0.39
MVP
0.84
MPC
0.29
ClinPred
0.025
T
GERP RS
5.9
Varity_R
0.34
gMVP
0.29
Mutation Taster
=2/98
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149253719; hg19: chr10-18795447; COSMIC: COSV56637041; API